Precision Medicine
in Parkinson’s disease:

Past lessons and conquering new frontiers

26 – 27 January 2023

About the Conference


The conference “Precision Medicine in Parkinson’s disease: past lessons and conquering new frontiers” is the third of a series of scientific conferences organised by the trilateral network Luxembourg-German-Indian Alliance on Neurodegenerative diseases and Therapeutics (Lux- GIANT). This alliance founded in 2014 aims to pursue transethnic genomic studies in neurodegenerative diseases such as Parkinson disease (PD).

The 2023 conference is organised by PD experts and key drivers of the Lux-GIANT community: Prof Rejko Krüger from the Luxembourg Centre for Systems Biomedicine (LCSB), Prof. Asha Kishore from India, and Dr Manu Sharma from University Hospital Tübingen.

They will address the work of the Lux- GIANT network while broadening its scope to include the expertise of key international speakers and participants. The format of the conference will cover the clinical phenotyping, genetic stratification and functional genomics of PD

The 2 days event brings together academia and clinicians to discuss research breakthroughs in the latest clinical development of PD, by examining the current research landscape and collaborating with significant international experts. We will hold six dedicated and complementary sessions:

Session 1: Cohorts and Clinical Phenotypes

Session 2: PD Genetics and genomics,

Session 3: Parkinson’s disease and Cognition – from risk factors for dementia in PD to prevention

Session 4: Genetics stratification for precision medicine

Session 5: From cellular mechanisms to novel biomarkers

Session 6: Data management and bioinformatics analysis

Dates: 26 – 27 JANUARY 2023
The event will take place on the Belval Campus, MSA 3.500
Open registration for this event will be available until 11 January 2023! Please check back for the conference registration link here.

Supported by the Luxembourg National Research Fund – RESCOM/2022/BM/17558083; by the Parkinson Foundation Grant number: PF-CA-11019843 and by the International Parkinson and Movement Disorder Society